Author

Eiichiro Yamamoto

Kumamoto UniversityORCID 0000-0001-8411-3448Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:host-pathogen & immune response· 1 Research Focus:metabolism & bioenergetics· 1 Assay:spatial transcriptomics· 1

Frequent Co-Authors

Kei MorikawaiD· 2 shared Kenichi TsujitaiD· 2 shared Shinsuke HanataniiD· 2 shared Takumi Nagakura· 2 shared Yasuhiro IzumiyaiD· 2 shared Yuichiro ArimaiD· 2 shared Akira Fujiyama· 1 shared Fumihiko OgataiD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersPhysiology

Kei MorikawaORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

PhysiologybioRxivPreprintSep 23, 2026

IL-17A Mediates Cardiac Hypertrophy in Chronic Kidney Disease through the IL-23/Th17 Axis.

Fumihiko Ogata, Shinsuke Hanatani, Yuki Okuno…·Kenichi Tsujita

This study shows that IL-17A promotes cardiac hypertrophy in CKD via the IL-23/Th17 axis, with IL-12p40 as a potential biomarker and therapeutic target.

DOI 10.64898/2026.09.17.752355

mouseexperimental assay

𝕏 PostBluesky

BiochemistrybioRxivPreprintFeb 2, 2026

Hepatic Ketogenesis Attenuates Cardiac Hypertrophy via Metabolic Reprogramming

Toshihiro Yamada, Kei Morikawa, Akira Fujiyama…·Yuichiro Arima

This study shows that hepatic ketogenesis reduces cardiac hypertrophy in HFpEF by maintaining beta-hydroxybutyrate levels, which modulate myocardial metabolism.

DOI 10.64898/2026.01.30.702687

mousebulk RNA-seq

𝕏 PostBluesky